greeksoup/ stock research

Eli Lilly (LLY) FY2023 results: revenue $34.1 billion, up 19.6% on the year

Eli Lilly & Co. (LLY) reported revenue of $34.1 billion for fiscal 2023, the year ended 31 December 2023, up 19.6% on the year before. Net income was $5.2 billion, down 16.1%, and diluted earnings per share $5.80. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2024.

Revenue
$34.1 billion
+19.6% on the year
FY2016FY2023
Operating margin
n/a
FY2016FY2023
Net income
$5.2 billion
-16.1% on the year
FY2016FY2023
Diluted EPS
$5.80
-15.9% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue34,12428,54128,318+19.6%
Cost of revenue7,0826,6307,313+6.8%
Gross profit27,04221,91221,006+23.4%
Gross margin79.2%76.8%74.2%
Research and development9,3137,1916,931+29.5%
Selling, general and administrative7,4036,4406,432+14.9%
Interest expense486332340+46.5%
Pre-tax income6,5556,8066,156-3.7%
Income tax1,314562574+134.0%
Effective tax rate20.1%8.3%9.3%
Net income5,2406,2455,582-16.1%
Net margin15.4%21.9%19.7%
Diluted EPS$5.80$6.90$6.12-15.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow4,2407,5867,366-44.1%
Capital expenditure3,4481,8541,310+85.9%
Free cash flow7925,7316,056-86.2%
Free cash flow margin2.3%20.1%21.4%
Cash from investing-7,153-3,763-2,868
Cash from financing3,496-5,407-4,131
Depreciation and amortisation1,5271,5221,548+0.3%
Share-based compensation628371343+69.4%
Buybacks7501,5001,250-50.0%
Dividends paid4,0693,5363,087+15.1%
Dividend per share$4.69$4.07$3.53+15.2%
Diluted shares, weighted903m905m912m-0.1%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity10,77210,6508,979+1.1%
Non-controlling interest91.8126176-26.9%
Debt25,22516,23916,885+55.3%
Operating lease liabilities948n/an/a
Other liabilities26,96922,47622,766+20.0%
Total liabilities and equity64,00649,49048,806+29.3%
Fixed assets12,91410,1448,985+27.3%
Goodwill4,9404,0733,892+21.3%
Intangible assets6,9077,2077,692-4.2%
Investments3,1613,0473,303+3.8%
Cash and equivalents2,8192,0673,818+36.4%
Receivables9,0906,8966,673+31.8%
Inventory5,7734,3103,886+33.9%
Other assets18,40311,74710,557+56.7%
Total assets64,00649,49048,806+29.3%

10-K for the year ended 31 December 2023, filed 21 February 2024: the filing.